Mayo Clinic Announces COVID Recommendation For Cancer Patients
Rochester, MN (KROC AM News) - Mayo Clinic is encouraging cancer patients to get a third dose of Covid vaccine.
Mayo’s recommendation deals with certain cancer patients who have received either the Moderna or Pfizer vaccines. Those who have received the Johnson & Johnson 19 vaccine do not need a third dose at the time.
Mayo’s announcement follows new recommendations from the National Comprehensive Cancer Network.
Here's who should receive a third dose of a messenger RNA COVID-19 vaccine:
- Patients with new or recurring solid tumors receiving treatment within one year of their initial vaccine dose, regardless of their type of cancer therapy.
- Patients with active blood cancers, regardless of whether they receive cancer therapy.
- Patients who received a stem cell transplant or engineered cellular therapy, such as chimeric antigen receptor-T cell therapy, especially within the past two years.
- Patients who received allogeneic stem cell transplants and are on immunosuppressive therapy or transplant patients with a history of graft-versus-host disease, regardless of transplant timing.
- Patients with an additional immunosuppressive condition, such as HIV or patients being treated with immunosuppressive agents unrelated to their cancer therapy.
- Review the updated vaccination guidelines for cancer patients on the National Comprehensive Cancer Network website.
Patients should contact their caretaker for more information.
KEEP READING: See 25 natural ways to boost your immune system